Salicylate Toxicity: Avoiding the Pitfalls - PowerPoint PPT Presentation

About This Presentation
Title:

Salicylate Toxicity: Avoiding the Pitfalls

Description:

Title: Salicylates and NSAID Toxicity Author: Carson Harris Last modified by: Property Of Created Date: 12/2/2001 10:31:21 PM Document presentation format – PowerPoint PPT presentation

Number of Views:101
Avg rating:3.0/5.0
Slides: 55
Provided by: Carson7
Category:

less

Transcript and Presenter's Notes

Title: Salicylate Toxicity: Avoiding the Pitfalls


1
Salicylate Toxicity Avoiding the Pitfalls
  • Carson R. Harris, MD, FAAEM, FACEP
  • Regions Hospital Clinical Toxicology Service
  • Emergency Medicine Department

2
Salicylates
  • Objectives
  • Discuss the toxicological effects of salicylate
    overdose
  • Identify key management issues
  • Discuss the limitations of the Done nomogram and
    how to avoid pitfalls of management

3
Salicylate Overdose
  • History and Demographics
  • Hippocrates 5th century B.C.
  • Powder from the willow bark
  • 1800s sodium salicylate for arthritis
  • Abdominal pain
  • Felix Hoffmann
  • Acetylsalicylic acid (ASA)
  • Introduced 100 years ago
  • Antipyretic, analgesic, anti-inflammatory

4
Salicylate Overdose
  • History and Demographics
  • Decline in use, but
  • Prophylactic for migraine, colon ca
  • Antiplatelet agent
  • Decline in incidence of Reyes
  • Childproof caps 1970s legislature
  • OTC meds
  • Combined with antihistamines, caffeine, barbs,
    and opioids

5
Salicylate Overdose
  • Salicylate formulations
  • Oil of wintergreen 98 methyl salicylate
  • 1400 mg/mL
  • Bismuth subsalicylate
  • Aggrenox

6
Salicylate Overdose
  • Therapeutic doses
  • Pediatric 10-20 mg/kg
  • Adults 650-1000 mg q 4-6 hrs
  • Produce a serum level of 5-10 mg/dL
  • Potential Toxic Acute dose gt 150 mg/kg
  • Serious toxicity 300-500 mg/kg
  • Chronic toxicity gt100 mg/kg/day

7
Salicylate Overdose
  • Peak levels
  • Therapeutic 1-2 hours
  • Therapeutic EC 4-6 hours
  • OD 10-60 hours
  • Reason for delay ? Concretions, contraction of
    the pylorus or combination of drugs that delay
    gastric emptying (opioids and anticholinergics)
  • Liquids absorbed in 1 hr

8
Salicylate Overdose
  • Distribution is facilitated by pH
  • Elimination dependent on dose
  • First order kinetic to zero order
  • From 4 hours to 15-29 hours

9
Case 1 ASA
  • A 24-year-old male presented to the ED with
    nausea, vomiting, tinnitus, and tachypnea after
    ingesting 100 aspirin tablets. His 4-hour
    salicylate level was 78 mg/dL Chem-8 revealed Na
    143, Cl 105, K 4.2, HCO3 17 the ABGs showed pH
    7.38, pO2 107, and pCO2 27 on room air. He was
    initially treated with reasonable volume and
    admitted to the ward.

10
Case 1 ASA
  • Orders for sodium bicarbonate were given to
    alkalinize the urine, but this was ineffective
    in raising urine pH. Approximately 6 hours later
    the attending was notified that the patient had
    become confused.
  • He was transferred to the ICU where he was
    sedated and intubated.

11
Case 1 ASA
  • Approximately 20 minutes after intubation, the
    patient rapidly deteriorated and died.

12
Salicylate Overdose Pathophysiology
  • ASA is hydrolyzed to salicylic acid
  • Responsible for therapeutic and toxic effects
  • Direct stimulation of respiratory center
  • Medulla
  • Uncouples oxidative phosphorylation
  • Increase in O2 consumption and CO2 production
  • Increase respiration
  • Respiratory alkalosis

13
Salicylate Overdose Pathophysiology
  • Renal excretion of bicarb, Na and K
  • Metabolic acidosis
  • Inhibition of mitochondrial respiration
  • Increase pyruvate and lactic acid
  • Metabolic acidosis
  • Disruption of Krebs cycle metabolism and
    glycolysis
  • Hyperglycemia, ketonemia

14
Salicylate Overdose Pathophysiology
  • Dehydration
  • Hyperpnea
  • Diaphoresis
  • Vomiting
  • Fever (increased muscle metabolism)
  • Vasoconstriction of auditory microvasculature
  • Enhance insulin secretion gt hypoglycemia
  • Decrease peripheral glucose utilization gt
    hyperglycemia

15
Salicylate Overdose Pathophysiology
  • Increase permeability of pulmonary vasculature
  • Increase the production of leukotrienes
  • Stimulate medullary chemoreceptor trigger zone
  • Hematologic effects

16
Salicylate Overdose Clinical Presentation
  • ASPIRIN Mnemonic
  • Altered mental status (lethargy coma)
  • Sweating/diaphoresis
  • Pulmonary edema
  • Increased vital signs (HTN, inc RR, inc T,
    tachycardia)
  • Ringing in the ears
  • Irritable
  • Nausea and vomiting

17
Salicylate Overdose Clinical Presentation
  • Early
  • Nausea, vomiting, diaphoresis, tinnitus, deafness
  • Level 25-30 mg/dL
  • Hyperventilation
  • Later
  • Hypotension, NCPE, oliguria, acidemia, cerebral
    edema, delirium, seizure, coma

18
Salicylate Overdose Clinical Presentation
  • Classic acid-base disturbance
  • AGMA
  • Respiratory alkalosis with metabolic acidosis
  • Acidemia
  • Increases tissue distribution
  • Brain, heart, lung
  • Severe hypokalemia

19
Salicylate Overdose Clinical Presentation
  • NCPE
  • Older patients
  • Smokers
  • Levels gt100 mg/dL
  • Acidemia
  • CNS involvement (hallucinations, sz)
  • Chronic toxicity

20
Clinical Presentation
Features Acute Chronic
Age Young adult Older adult/infants
Etiology Overdose RX misuse
Co-ingestions Frequent Rare
Mental status Normal Altered
Presentation Early Late
Mortality Low w/ Rx High
Serum levels 40 to gt120 30 to gt80
21
Salicylate Overdose Laboratory studies
  • Salicylate level
  • Peak 4-6 hr
  • EC and SR preparations late rise
  • Every 2-4 hours until clearly decreasing
  • Then q 4-6 until lt30 mg/dL
  • Always confirm units!
  • Mg/dL vs. mg/L
  • Done Nomogram (Pediatrics 1960)

22
Done Nomogram
  • NOT USEFUL for
  • Chronic ingestions
  • Liquid preparations
  • EC or SR
  • Acidemia
  • Renal failure
  • Unknown time of ingestion
  • Methylsalicylate

23
Laboratory studies
  • Severity of ingestion
  • Serum levels
  • Acid-base status
  • Acuteness of ingestion
  • Mental status
  • Bedside Tests
  • Trinders reagent 10 ferric chloride
  • Ames phenistix

24
Laboratory studies
  • Chemistry Panel
  • Q 4-6 h
  • LFTs
  • Coagulation studies
  • ABGs
  • APAP
  • Consider CT, Serum osm, ketones, LP, CO, serum
    Fe, blood cultures

25
Treatment
  • Gastric lavage / WBI
  • Activated charcoal - MDAC
  • Hydration and electrolyte replacement
  • Correct hypokalemia aggressively
  • Urine alkalinization
  • Increase salicylate excretion
  • 1-2 mEq/kg NaHCO3 bolus IV
  • Then 150 mL in 850 ml D5W run 1.5-2 times
    maintenance
  • Caution in elderly and chronic
  • Monitor UO

26
Treatment
  • Dialysis
  • Serum levels gt 100 in acute
  • Levels gt 60 in chronic
  • Pulmonary edema
  • Renal failure
  • CHF
  • Poor response to standard Rx
  • AMS and acidemia

27
ASA Pearls
  • Enteric Coated aspirin
  • Can cause delayed symptom onset
  • Don't wait for clinical deterioration.
  • Alert you nephrology team early and call the
    poison center even earlier.
  • Serial salicylate levels are imperative.

28
ASA Pearls
  • One teaspoon of methyl salicylate contains 7,000
    mg of salicylate which is equivalent to
    approximately 21 regular strength aspirin
    tablets!
  • The presence of fever is a poor prognostic sign
    in adults!
  • Cerebrospinal fluid salicylate levels correlate
    with symptoms better than blood levels

29
ASA Pearls
  • The Done nomogram, has limited usefulness
  • Be aware of the proper unit of measure
  • (mg/dL not mg/L or µg/L or mmol/L)!

30
ASA Pearls
  • Start potassium supplementation early (in the
    absence of renal insufficiency) because
    hypokalemia makes urinary alkalization
    impossible!
  • Multiple-dose activated charcoal and
    alkalinization are currently the most popular
    methods of treatment.

31
ASA Pearls
  • Be aggressive. Dialyze early if signs of toxicity
    are evident.

32
ASA Pearls
  • ASA and elderly
  • Impaired renal function
  • Decreased elimination
  • Impaired hepatic function
  • The risk of salicylate nephrotoxicity is
    increased with age,
  • Upper gastrointestinal bleed is associated with
    increased mortality in older age groups.

33
Questions???
34
CA Overdose
  • Mortality and Epidemiology
  • From 15 to 1.7 in 1977
  • Second leading cause of death from overdose in US
    (Analgesics first).
  • Approximately 500,000 overdoses annually
  • Female, age 20-29, single, employed, no history
    of drug abuse
  • Approximately 70 die pre-hospital

35
TCA Overdose
  • Indications
  • Depression
  • Chronic pain syndromes
  • OCD
  • Panic and Phobic disorders
  • Migraine prophylaxis
  • Peripheral neuropathies

36
CA Overdose
  • Acute Toxic Doses
  • Fatal ingestions range 10-210 mg/kg
  • 2-4 mg/kg is therapeutic, 20 mg/kg is potentially
    fatal
  • Variable response

37
CA - Pharmacokinetics
  • Absorption
  • Rapidly and completely absorbed
  • Massive OD delays absorption
  • Enterohepatic re-circulation secretes 30
  • Distribution
  • Wide range in Vd (15-40 L/kg)
  • Genetic variation
  • Lipophilic
  • Elderly has higher Vd

38
CA - Pharmacokinetics
  • Distribution (contd)
  • Tissue levels usually 10 times plasma levels
  • Protein binding usually exceeds 90 with some
    variations
  • pH dependent
  • Elimination
  • Genetic component
  • Metabolism influenced by other drugs

39
CA - Pathophysiology
  • Therapeutic effects
  • Not completely understood
  • Blocks serotonin and NE uptake
  • Anticholinergic effects
  • Cardiac Effects
  • Sinus tachycardia, dysrhythmias
  • Na channel blockade quinidine effect
  • Hypotension
  • Alpha adrenergic blockade and NE depletion
  • Conduction delays / blocks

40
CA - Pathophysiology
  • CNS
  • Anticholinergic
  • Excitation, confusion, hallucination, ataxia
  • Seizures
  • Coma

41
CA - Pathophysiology
  • Respiratory
  • Pulmonary edema
  • ARDS
  • Aspiration pneumonia
  • Gastrointestinal
  • Delayed gastric emptying
  • Decreased motility
  • Prolonged transit time

42
CA Clinical Presentation
  • Case 1
  • 25 year-old man ingested 60 tablets of Elavil 50
    mg each. He presented to the ED about 45 minutes
    post ingestion agitated and confused. Possibly
    hallucinating. BP 145/94, P 112, R22, T99.6. He
    became more agitated and combative and was
    intubated, lavaged and given AC.
  • EKG revealed QRS 108 with rate 114
  • What are the critical ECG changes?

43
TCA ECG Changes
  • Prolongation of the QRS complex
  • Blockage of fast sodium channels slows phase 0
    depolarization of the action potential.
  • Ventricular depolarization is delayed, leading to
    a prolonged QRS interval. Patients with QRS
    intervals gt100 ms are at risk for seizures and
    patient with QRS intervals gt160 ms are at risk
    for arrhythmias.
  • QRS interval is evaluated best using the limb
    leads.

44
CA Overdose ECG 1
45
(No Transcript)
46
TCA ECG Changes
  • R wave in aVR gt3 mm
  • greater selectivity and toxicity to the distal
    conduction system of the right side of the heart.
  • effect can be observed as an exaggerated height
    of the R wave aVR.
  • may be more predictive of seizure and arrhythmia
    than prolongation of the QRS complex.
  • R/S ratio gt0.7 in aVR
  • QT interval prolongation
  • Arrhythmias
  • How do you treat this?

47
CA Toxicity Treatment
  • ABCs
  • Activated Charcoal 30-50 gm
  • Sodium Bicarbonate
  • Dose
  • Endpoint
  • What is the mechanism?

48
TCA Toxicity Treatment
  • Alkalinization
  • appears to uncouple TCA from myocardial sodium
    channels.
  • Alkalinization may increase protein binding
  • Increases the extracellular sodium concentration
  • improves the gradient across the channel.

49
TCA Toxicity Treatment
  • The initial bolus of 1-2 mEq/kg
  • A constant infusion of sodium bicarbonate
  • commonly accepted clinical practice without any
    controlled studies validating the optimum
    administration
  • 100 to 150 mEq of sodium bicarbonate to each
    liter of 5 dextrose,
  • the resulting solution is hypotonic or nearly
    isotonic.

50
TCA Toxicity Treatment
  • What if NaHCO3 doesnt work?
  • may require treatment with lidocaine and/or
    magnesium sulfate.
  • Class Ia and Ic agents contraindicated
  • Beta blockers and CCB
  • Worsen or potentiate hypotension

51
TCA Toxicity Treatment
  • Hypotension, Persistent
  • Direct acting alpha agonists, such as
    norepinephrine and phenylephrine
  • Dopamine may not be as effective
  • Require release of endogenous catecholamines that
    may be depleted during TCA toxicity.
  • Dopamine or dobutamine alone may result in
    unopposed beta-adrenergic activity due to TCA
    induced alpha blockade and, therefore, may worsen
    hypotension.
  • Vasopressin (ADH)

52
TCA Toxicity Treatment
  • What about Seizures from TCA
  • Usually brief (lt1 min)
  • self-limiting
  • acidosis increase cardiovascular toxicity.
  • Benzodiazepines
  • Phenytoin is no longer recommended
  • limited efficacy and possible prodysrhythmic.
  • Phenobarbital may be used as a long-acting
    anticonvulsant.

53
TCA Toxicity Treatment
  • Agitation from TCA
  • Anticholinergic effects
  • Benzodiazepines are also the treatment of choice
  • Physostigmine is contraindicated in TCA overdoses
  • May cause bradycardia and asystole in the setting
    of TCA cardiotoxicity.
  • Flumazenil is contraindicated even in the
    presence of a benzodiazepine co-ingestion.
  • Several case reports - seizures

54
TCA Overdose
  • Emergency department discharge criteria
  • At least 6 hour observation period
  • No significant sign of toxicity during
    observation period, including normal follow-up
    ECG prior to discharge
  • Accidental ingestion
  • Appropriate follow-up measures in place
  • Adequately supervised home environment
Write a Comment
User Comments (0)
About PowerShow.com